HeartFlow Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-125.37	-96.43	-95.66
Depreciation & Amortization	3.42	4.39	4.43
Other Amortization	10.7	5.31	5.98
Stock-Based Compensation	11.22	10.21	11.87
Provision & Write-off of Bad Debts	-0.42	-0.24	1.19
Other Operating Activities	30.91	2.02	1.01
Change in Accounts Receivable	-4.36	-3.85	-9.35
Change in Accounts Payable	0.35	-0.33	-0.62
Change in Other Net Operating Assets	16.07	9.91	4.71
Operating Cash Flow	-57.47	-69	-76.43
Capital Expenditures	-3.46	-4.36	-6.11
Investing Cash Flow	-3.46	-4.36	-6.11
Issuance of Common Stock	336.59	4.56	0.59
Repurchase of Common Stock	-	-	-0.23
Other Financing Activities	-7.28	-2.33	-
Financing Cash Flow	286.94	2.24	169.32
Foreign Exchange Rate Adjustments	0.49	-0.27	-0.5
Net Cash Flow	226.51	-71.39	86.28
Free Cash Flow	-60.92	-73.36	-82.54
Free Cash Flow Margin	-37.63%	-58.31%	-94.68%
Free Cash Flow Per Share	-3.59	-13.68	-16.89
Cash Interest Paid	12.67	19.16	20.8
Cash Income Tax Paid	0.09	-0.07	0.41
Levered Free Cash Flow	-	-41.66	-
Unlevered Free Cash Flow	-	-29.04	-
Change in Working Capital	12.07	5.74	-5.26

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q